Advertisement
Canada markets closed

  • S&P/TSX

    21,728.55
    +14.01 (+0.06%)
     

  • S&P 500

    5,018.39
    -17.30 (-0.34%)
     

  • DOW

    37,903.29
    +87.37 (+0.23%)
     

  • CAD/USD

    0.7281
    +0.0020 (+0.28%)
     

  • CRUDE OIL

    79.13
    -2.80 (-3.42%)
     

  • Bitcoin CAD

    79,273.27
    -3,360.10 (-4.07%)
     

  • CMC Crypto 200

    1,202.07
    -136.99 (-10.23%)
     

  • GOLD FUTURES

    2,330.20
    +27.30 (+1.19%)
     

  • RUSSELL 2000

    1,980.23
    +6.32 (+0.32%)
     

  • 10-Yr Bond

    4.5950
    -0.0910 (-1.94%)
     

  • NASDAQ futures

    17,474.75
    -96.50 (-0.55%)
     

  • VOLATILITY

    15.39
    -0.26 (-1.66%)
     

  • FTSE

    8,121.24
    -22.89 (-0.28%)
     

  • NIKKEI 225

    38,274.05
    -131.61 (-0.34%)
     

  • CAD/EUR

    0.6796
    -0.0006 (-0.09%)
     

Today’s Research Reports on Medicure, Hamilton Thorne, Hemostemix and Cotinga Pharmaceuticals

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / May 23, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI has Initiated Coverage Today on:

Medicure Inc.
https://rdinvesting.com/news/?ticker=MPH.V

Hamilton Thorne Ltd.
https://rdinvesting.com/news/?ticker=HTL.V

Hemostemix Inc.
https://rdinvesting.com/news/?ticker=HEM.V

Cotinga Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=COT.V

Medicure's stock edged 0.81% higher Tuesday, to close the day at $6.20. The stock recorded a trading volume of 2,615 shares, which was below its three months average volume of 23,801 shares. In the last year, Medicure's shares have traded in a range of 5.56 - 9.20. The stock is currently trading 32.61% below its 52 week high. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $6.38 is below its 200-day moving average of $7.10. Shares of the company are trading at a Price to Earnings ratio of 6.98. Shares of Medicure have fallen approximately 16.78 percent year-to-date.

ADVERTISEMENT

Access RDI's Medicure Inc. Research Report at:
https://rdinvesting.com/news/?ticker=MPH.V

On Tuesday, shares of Hamilton Thorne recorded a trading volume of 28,600 shares, which was below the three months average volume of 63,616 shares. The stock ended the day 1.22% higher at 0.83. The share price has gained 23.88% from its 52 week low with a 52 week trading range of 0.67 - 1.05. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.83 is greater than its 200-day moving average of $0.77. Shares of Hamilton Thorne are trading at a Price to Earnings ratio of 16.60. Shares of Hamilton Thorne have gained approximately 10.67 percent year-to-date.

Access RDI's Hamilton Thorne Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=HTL.V

Hemostemix's stock had no change Tuesday, to close the day at $0.07. The stock recorded a trading volume of 56,611 shares, which was below its three months average volume of 348,744 shares. In the last year, Hemostemix's shares have traded in a range of 0.05 - 0.16. The share price has gained 40.00% from its 52 week low. The company's shares are currently trading at their 200-day moving average. The stock's 50-day moving average of $0.07 is at its 200-day moving average of $0.07.

Access RDI's Hemostemix Inc. Research Report at:
https://rdinvesting.com/news/?ticker=HEM.V

On Tuesday, shares of Cotinga Pharmaceuticals recorded a trading volume of 14,951 shares, which was below the three months average volume of 16,968 shares. The stock ended the day 6.00% lower at 0.94. The share price has gained 224.14% from its 52 week low with a 52 week trading range of 0.29 - 3.50. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.55 is below its 200-day moving average of $0.80. Shares of Cotinga Pharmaceuticals have fallen approximately 14.55 percent year-to-date.

Access RDI's Cotinga Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=COT.V

Our Actionable Research on Medicure Inc. (TSXV :MPH.V), Hamilton Thorne Ltd. (TSXV :HTL.V), Hemostemix Inc. (TSXV :HEM.V) and Cotinga Pharmaceuticals Inc. (TSXV :COT.V) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com